This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
M&A chatter centers on mid-cap SaaS names ASAN, FRSH, and PD as buyers hunt for platform fit and durable ARR. Here’s ...
MAGY, the MAGY Magnificent Seven Covered Call ETF, now offers a Monday-morning income payout. The fund uses an active...
The AI gold rush has turbocharged demand for specialized chips. Morgan Stanley warns of chipflation as hyperscalers i...
Vale’s shares fell as iron ore demand in China cooled, signaling wider margin pressures for metals. This guide breaks...
Tech-led selling pushed the Nasdaq Composite lower as investors weigh higher yields and fresh data. The broader marke...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
AI optics stocks pull back after a prolonged rally, with Applied Optoelectronics slumps 10% as LUMENTUM and Coherent ...
A quiet quantum player is showing real-world traction while the hype focuses on the big names. This analysis reveals ...
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
Tech stocks retreat as geopolitical tensions escalate and oil climbs, sending the live nasdaq composite: tech lower a...
DHT Holdings has benefited from surging tanker rates and a policy of distributing all ordinary net income as dividend...